Chinese scientists who cure type I diabetes can win the Nobel Prize in medicine
AD |
On July 11, Peking University released information that Peking University Stem Cell Center cooperated with Tianjin First Central Hospital to successfully complete the islet cell transplantation of the first international type I diabetes subject. A patient with 11 years' history of type I diabetes underwent surgery and resumed normal activities on the day after transplantation
On July 11, Peking University released information that Peking University Stem Cell Center cooperated with Tianjin First Central Hospital to successfully complete the islet cell transplantation of the first international type I diabetes subject. A patient with 11 years' history of type I diabetes underwent surgery and resumed normal activities on the day after transplantation. On the 10th day after transplantation, the patient's blood sugar remained stable and their daily insulin requirement had been reduced to half of before transplantation. The transplanted islet cells will further mature in the patient's body, and the treatment effect will gradually reach a stable state within a few months after transplantation. This treatment technology is expected to become the best solution to completely cure Type 1 diabetes, which means that the incurable diabetes has the possibility of complete cure.
If we can further verify the technical reliability of stem cell transplantation for the treatment of type I diabetes, this technology is not only the gospel of 420 million diabetes patients worldwide (40 million type I patients), but also a major breakthrough in the medical technology of stem cell therapy, which is no less significant than the discovery of penicillin in the same year, and has epoch-making milestone significance in medicine.
The Nobel Prize in Physiology or Medicine is the highest honor that can be obtained in the field of human medicine. diabetes is the biggest chronic disease afflicting mankind in modern society. The Chinese scientists who cure type I diabetes are fully equipped with the conditions and strength to win the Nobel Prize in Medicine. For this reason, we will wait and see, and wish our scientists more and greater breakthroughs.
Disclaimer: The content of this article is sourced from the internet. The copyright of the text, images, and other materials belongs to the original author. The platform reprints the materials for the purpose of conveying more information. The content of the article is for reference and learning only, and should not be used for commercial purposes. If it infringes on your legitimate rights and interests, please contact us promptly and we will handle it as soon as possible! We respect copyright and are committed to protecting it. Thank you for sharing.(Email:[email protected])
Mobile advertising space rental |
Tag: Chinese scientists who cure type diabetes can win the
Shanzhai Twitter has 100 million users. Musk couldn't sit still and directly called Xiao Zha a "pervert"
NextNot as skilled as humans? China spent 140 million US dollars on the moon, while India spent 75 million US dollars on Chandrayaan-3
Guess you like
-
The 2025 Chinese New Year (Spring Festival) film box office has exploded, exceeding 3 billion RMB and setting a new record for presales!Detail
2025-01-29 11:55:06 1
-
Seres and Beihang University Join Hands to Build an Innovative Ecosystem, Deepening Industry-Academia-Research Collaboration and Promoting Technological TransformationDetail
2025-01-28 14:46:18 1
-
Douyin 2024 Platform Governance Report: Safeguarding Security, Building a Better CommunityDetail
2025-01-28 14:25:55 1
-
Chinese Scientists Develop a Lightweight Bionic Dexterous Hand with 19 Degrees of Freedom, Promising to Revolutionize Prosthetic and Robotics TechnologyDetail
2025-01-28 14:16:39 1
-
DeepSeek: A Chinese AI Startup's Meteoric Rise Shakes Up Global Tech and Sends US Stocks PlungingDetail
2025-01-28 14:13:23 1
-
WeChat's New Year's Red Envelope Feature Gets a Voice Message Upgrade for Warmer Wishes!Detail
2025-01-26 11:37:36 1
-
360 Digital Security Group and Zhibangyang Education Technology Join Forces to Build a New Ecosystem for Cybersecurity and AI Talent CultivationDetail
2025-01-24 15:09:51 1
-
Visionox Achieves Mass Production of AMOLED with Solid-State Laser Annealing (SLA) Technology, Ushering in a New Era for the Display IndustryDetail
2025-01-24 14:34:23 1
-
Seres at the Davos Forum: The Path to Globalizing New Energy Vehicles Through Cooperation in the Intelligent EraDetail
2025-01-23 13:28:12 1
-
Amazon to Close All French-Speaking Quebec Warehouses, Laying Off Nearly 2,000 EmployeesDetail
2025-01-23 10:51:23 1
-
The official launch of the 2025 Electric Bicycle Trade-in Policy: Upgraded Subsidy Standards, Procedures, and PromotionDetail
2025-01-23 10:48:52 1
-
Xbox Series X|S Officially Supports External Hard Drives Larger Than 16TB: Saying Goodbye to Storage WorriesDetail
2025-01-23 10:39:19 1
-
Leaders from the Beijing Chaoyang District CPPCC Visited Quantum Leap Group, Affirming its Contributions and Future Prospects in the Silver Hair EconomyDetail
2025-01-22 17:06:56 1
-
China's Car Imports Remain Sluggish in 2024: 12% Decline, Sharp Drop in New Energy VehiclesDetail
2025-01-22 11:37:25 1
-
China Railway Group Limited (CRGL) officially debunks "speed-up" ticket booking software: Not a shortcut, but a pathway to riskDetail
2025-01-22 11:36:09 1
-
Dago Bio Completes Over $20 Million A+ Round Funding to Accelerate Novel Molecular Glue Drug DevelopmentDetail
2025-01-22 11:34:05 11
-
Rapid Degradation of Global Lake Submerged Vegetation: Satellite Observations Reveal a Critical Period of Ecosystem ShiftDetail
2025-01-22 11:29:03 1
-
Star Ace Capital Group and Abu Dhabi Investment Office Partner to Build a Global Esports Industry BenchmarkDetail
2025-01-22 11:27:50 1
-
Hisense Television Leads the 100-Inch Large-Screen Market in 2024, Achieving an Unparalleled Industry LegacyDetail
2025-01-22 11:12:49 1
-
WeChat Launches "Gifts" Feature: Streamlining Gift-Giving and Powering Social Commerce GrowthDetail
2025-01-21 16:05:45 1